Galmed Pharmaceuticals Ltd. buy Needham & Company LLC
Start price
25.02.26
/
50%
€6.40
Target price
25.02.27
€96.72
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 25.02.27. The prediction end date can be changed by Needham___Company_LL at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - |
| iShares Core DAX® | -0.676% | 4.053% |
| iShares Nasdaq 100 | 0.993% | 10.872% |
| iShares Nikkei 225® | 3.279% | 13.468% |
| iShares S&P 500 | 0.621% | 6.195% |
Comments by Needham___Company_LL for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical (GMED) had its price target raised by Needham & Company LLC from $112.00 to $114.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Needham___Company_LL for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
08.05.26
08.05.26
€99.77
08.05.27
08.05.27
-
19.09.24
19.09.24
